Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Shahamat, Tauhid"'
Autor:
Christopher C. Hemond MD, Rohit Bakshi MD, MA, Shahamat Tauhid MD, Rosila Sarrosa, Madison Ryan, Vineetha Kamath, James Thomas MD, Keith R. Edwards MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
The emergence of immunomodulators as effective cancer treatments has been an important advance in cancer therapy. The combination therapy of BRAF/MEK inhibition with or without anti-CTLA-4 treatment causes an immunostimulatory effect that has greatly
Externí odkaz:
https://doaj.org/article/e59259cab910488994de5cafcb6872b4
Autor:
Akram Dastagir, Brian C. Healy, Alicia S. Chua, Tanuja Chitnis, Howard L. Weiner, Rohit Bakshi, Shahamat Tauhid
Publikováno v:
eNeurologicalSci, Vol 12, Iss , Pp 42-46 (2018)
Background: Primary progressive (PP) multiple sclerosis (MS) is considered a clinically distinct entity from the spectrum of relapsing-remitting (RR) forms of the disease. Objective: To compare the presence of brain and spinal cord lesions between PP
Externí odkaz:
https://doaj.org/article/caaa072878a6441e94007abe34eeb3bd
Autor:
Alessandra M. Valcarcel, Kristin A. Linn, Fariha Khalid, Simon N. Vandekar, Shahamat Tauhid, Theodore D. Satterthwaite, John Muschelli, Melissa Lynne Martin, Rohit Bakshi, Russell T. Shinohara
Publikováno v:
NeuroImage: Clinical, Vol 20, Iss , Pp 1211-1221 (2018)
Background and purpose: Magnetic resonance imaging (MRI) is crucial for in vivo detection and characterization of white matter lesions (WML) in multiple sclerosis (MS). The most widely established MRI outcome measure is the volume of hyperintense les
Externí odkaz:
https://doaj.org/article/eb0e15610a8b4fe9b647926ce65394a3
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background The cerebral subcortical deep gray matter nuclei (DGM) are a common, early, and clinically-relevant site of atrophy in multiple sclerosis (MS). Robust and reliable DGM segmentation could prove useful to evaluate putative neuroprot
Externí odkaz:
https://doaj.org/article/2282272cb24849ceb3e8104306c7534f
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206939 (2018)
BACKGROUND:Cerebral atrophy is common in multiple sclerosis (MS) and selectively involves gray matter (GM). Several fully automated methods are available to measure whole brain and regional deep GM (DGM) atrophy from MRI. OBJECTIVE:To assess the sens
Externí odkaz:
https://doaj.org/article/d7a3f704ee5f4ead85df347070c16323
Autor:
Keith R. Edwards, Daniel Harrison, Maria K. Houtchens, Shahamat Tauhid, Shamik Bhattacharyya, Mahsa Khayat-Khoei, Penny Bruso, Rohit Bakshi, Joshua Katz
Publikováno v:
Journal of Neurology
The availability of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID-19) pandemic. Vaccine safety and efficacy has not been established in indiv
Autor:
Regina Berkovich, Rohit Bakshi, Lilyana Amezcua, Robert C. Axtell, Steven Y. Cen, Shahamat Tauhid, Mohit Neema, Lawrence Steinman
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 10 (2017)
Background: The objective of this study was to evaluate monthly intramuscular adrenocorticotropic hormone (ACTH) gel versus intravenous methylprednisolone (IVMP) add-on therapy to interferon β for breakthrough disease in patients with relapsing form
Externí odkaz:
https://doaj.org/article/669da6c82be84a56bc0897534748db53
Autor:
Mahmoud A. AbdelRazek, Subhash Tummala, Fariha Khalid, Shahamat Tauhid, Youmna Jalkh, Samar Khalil, Shelley Hurwitz, Jonathan Zurawski, Rohit Bakshi
Publikováno v:
Journal of the neurological sciences. 444
Cerebral gray matter (GM) atrophy is a proposed measure of neuroprotection in multiple sclerosis (MS). Glatiramer acetate (GA) limits clinical relapses, MRI lesions, and whole brain atrophy in relapsing-remitting MS (RRMS). The effect of GA on GM atr
Autor:
Shahamat Tauhid, Howard L. Weiner, Idanis Berriosmorales, Tamara H.W. Schwartz, Mark S. Freedman, Carolina Ionete, Rohit Bakshi, Biljana D. Beretich, Jacob A. Sloane, Ann Cabot, Paolo Preziosa, Amir-Hadi Maghzi, James Stankiewicz, Massimo Filippi, Maria K. Houtchens
Publikováno v:
Journal of Neurology
The outbreak of a severe acute respiratory syndrome caused by a novel coronavirus (COVID-19), has raised health concerns for patients with multiple sclerosis (MS) who are commonly on long-term immunotherapies. Managing MS during the pandemic remains
Autor:
Vineetha Kamath, Shahamat Tauhid, Madison Ryan, Christopher C. Hemond, Keith R. Edwards, Rohit Bakshi, James Thomas, Rosila Sarrosa
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
Journal of Investigative Medicine High Impact Case Reports
Journal of Investigative Medicine High Impact Case Reports
The emergence of immunomodulators as effective cancer treatments has been an important advance in cancer therapy. The combination therapy of BRAF/MEK inhibition with or without anti-CTLA-4 treatment causes an immunostimulatory effect that has greatly